Clinical Trial Update: A Long-term Follow-up Study in Participants Who Received CS-101 [NA]

View source ↗

Summary

A long-term follow-up study of participants who received CS-101 for beta-thalassemia is ongoing, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• CS-101

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Beta-Thalassemia | NA | Status: RECRUITING